The IMID Forum Author Interview: Professor Andrea Rubbert-Roth, 2023
Jan 22, 2024
Join Professor Andrea Rubbert-Roth, a doctor of rheumatology, as she discusses the incidence of malignancy in rheumatology patients, the impact of EMA guidance on Jack inhibitors prescribing in Switzerland, the use of UVA poova treatment, and the challenges of long-term immunosuppression after oncology treatment.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
EMA Guidance on Jack Inhibitors Prescribing in Switzerland
02:58 • 14min
Comparison of UVA Poova Treatment and TNS Plus Poova in Switzerland
16:34 • 3min
Treatment Approach for Patients with Previous Malignancy
19:27 • 3min
Challenges of Long-Term Immunosuppression in Patients with a Malignancy
22:40 • 2min